What happened
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
SourceCFI-FCIpublicationBiotech
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Publication signal: Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Factual summary
Why it matters
Recent source-backed research output for AISci Stage A browsing.
SourceCFI-FCILimitations
AISci rank score does not assess scientific quality or citation impact.
SourceCFI-FCILinked output
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.paperPeople
No reviewed person relationship is attached to this event.
Organizations
No reviewed organization relationship is attached to this event.
Topics
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Protein and Drug Design
Controlled AISci Stage A topic for Protein and Drug Design.
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Toronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.
Timeline
- publicationToronto Western “Investigational New Drug" Design & Discovery Lab (WIN-D3): an innovative centre of drug design and discovery for protein misfolding disorders, stroke, retinopathy and epilepsy.